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Mitochondrial dysfunction is a significant factor inhumandisease, ranging fromsystemicdisordersof childhood
to cardiomyopathy, ischaemia and neurodegeneration. Cytochrome oxidase, the terminal enzyme of the mito-
chondrial respiratorychain, isa frequent target. Lowereukaryotespossessalternative respiratory-chainenzymes
thatprovidenon-proton-translocatingbypassesforrespiratorycomplexes I (single-subunit reducednicotinamide
adenine dinucleotide dehydrogenases, e.g. Ndi1 from yeast) or III1 IV [alternative oxidase (AOX)], under condi-
tionsof respiratory stress oroverload. In previousstudies, itwas shown that transfer of yeastNdi1orCiona intes-
tinalisAOXtoDrosophilawasable toovercome the lethalityproducedby toxinsorpartial knockdownofcomplex I
or IV. Here, we show that AOX can provide a complete or substantial rescue of a range of phenotypes induced by
globalor tissue-specificknockdownofdifferentcIVsubunits, including integralsubunits requiredforcatalysis,as
well as peripheral subunits required formultimerization and assembly. AOXwas also able to overcome the pupal
lethality produced by muscle-specific knockdown of subunit CoVb, although the rescued flies were short lived
and had a motility defect. cIV knockdown in neurons was not lethal during development but produced a rapidly
progressing locomotor and seizure-sensitivity phenotype, which was substantially alleviated by AOX.
Expression of Ndi1 exacerbated the neuronal phenotype produced by cIV knockdown. Ndi1 expressed in place
of essential cI subunits produced a distinct residual phenotype of delayed development, bang sensitivity and
male sterility. These findings confirm the potential utility of alternative respiratory chain enzymes as tools to
combat mitochondrial disease, while indicating important limitations thereof.
INTRODUCTION
Mitochondrial diseases affecting the respiratory complexes of
the oxidative phosphorylation (OXPHOS) system are a diverse
collection of pathologies, which can affect almost any tissue,
at any age (1,2). They are typically progressive in nature, and
no effective treatments are currently available. Where genetic
causes are known, they can include lesions in any of hundreds
of genes whose products are needed for the biosynthesis or
function of the respiratory complexes. These genes, moreover,
are distributed between nuclear and mitochondrial DNA
(mtDNA), and a subset of mitochondrial diseases also results
from defective communication between the cell’s two genomes.
In order to understand better the pathophysiological mechan-
isms of mitochondrial disease, and develop a possible strategy
for eventual therapy, we have exploited the fact that lower eukar-
yotes, including plants and many invertebrates, possess an alter-
native, non-proton-pumping respiratory chain in mitochondria,
whose components can act as a bypass of the OXPHOS system
under conditions of respiratory stress or overload (3,4). Alterna-
tive reduced nicotinamide adenine dinucleotide(NADH) dehy-
drogenases such as yeast Ndi1 can replace complex I (cI),
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while alternative oxidases (AOXs) can replace complexes III +
IV (cIII + IV). The alternative enzymes are each composed of a
single gene product, which together conduct electrons from
NADH to molecular oxygen via ubiquinone as an intermediate
electron acceptor. AOX becomes enzymatically active only
when electron transfer via the OXPHOS system becomes inhib-
ited beyond ubiquinone. The main mechanism to achieve this is
believed to be that AOX has a much higher Km for its substrate,
ubiquinol, than does cIII. In contrast, Ndi1 may be constitutively
active, but its role in electron flow under normal physiological
conditions may be limited by the tight coupling between cI and
cIII in supercomplexes.
Like Ndi1, AOX is absent from vertebrates, as well as arthro-
pods (5), but we reasoned that if the gene product were trans-
ferred to higher metazoans it might be able to functionally
replace the corresponding OXPHOS complexes under condi-
tions resembling those pertaining in mitochondrial disease.
When expressed transgenically in human cells (6,7),Drosophila
(8) or most recently the mouse (9), AOX from the urochordate
Ciona intestinalis was shown to be enzymatically functional
when cIII or cIV was inhibited by specific toxins, or genetic mu-
tation. Similarly, when yeast Ndi1 was transferred to mamma-
lian cells or to Drosophila, it was functional, enabling NADH
oxidation when cI was inhibited by rotenone (10). Remarkably,
the ubiquitous presence of these alternative enzymes is tolerated
by the whole organism, to which it can confer toxin resistance
in vivo (8–10). In wild-type flies, no deleterious phenotype is
produced by constitutive AOX (or Ndi1) expression (8,10).
However, the alternative enzymes can overcome the lethality
produced by partial knockdown of at least some subunits of
the corresponding OXPHOS complexes, including two subunits
of the membrane portion of cI (10), a nuclear-coded ‘supernumer-
ary’ subunit of cIV [Cox6c, the cyclope gene product (8)] and a
cIV assembly factor, Surf1 (8). Note, however, that AOX
cannot complement the total loss of cIV, e.g. via a null mutation
in Cox6c (9).
The structure of metazoan cIV is relatively well understood
(11). It comprises a catalytic core, composed of the three
mtDNA-encoded subunits, whose functional assembly is de-
pendent on a set of phylogenetically conserved nuclear-coded
subunits (Cox4, Cox5a, Cox5b, Cox6b, Cox6c, probably Cox7c,
Cox8, using the mouse nomenclature) required to produce, via a
stepwise assembly pathway, a membrane-bound sub-complex
with enzymatic activity (12,13). The incorporation of prosthetic
groups (a-type haemes and copper) is also involved in this
process. The other nuclear-coded subunits (Cox6a and Cox7a)
are then incorporated to form the fully functional cIV, which
also contains a recently described subunit (14) formerly believed
to be a constituent of cI. Some of these subunits, notably Cox6a,
are believed to be important for dimerization of the complex
and, together with other specific proteins such as Rcf1
(HIG2A) and Cox7RP, may also be required for the formation
of supercomplexes containing cIV, as well as cI and/or cIII in dif-
ferent stoichiometries (15–18). The more specific roles of the
nuclear-coded subunits of cIV (often termed ‘supernumerary’
since they are absent in bacteria), for example in physiological
regulation, are less clear. Null mutations in most of the above
subunits are lethal inDrosophila, whereas a splice-site mutation
in the levy gene, encoding subunit Cox6a, produces an
adult-onset neurodegenerative phenotype (19).
Cytochrome coxidase (COX) deficiency in humans has a wide
variety of pathological manifestations and a diversity of genetic
causes (20,21). Organs affected can be the central nervous
system, skeletal or heart muscle, the liver or a combination of
these and other organs, and tissue-specificity is poorly under-
stood. Underlying genetic defects commonly impact accessory
factors for cIV biosynthesis, including assembly factors such
as SURF1 (22,23) or C2ORF64 (24) or proteins involved in co-
factor synthesis or transport, such as SCO2 (25) and COX10
(26). Comparatively rare mutations are also found in genes for
structural subunits of cIV, such as COX6B1 (27) or COX7B
(28), as well as those encoded in mtDNA (29–31), plus genes
required mainly or exclusively for the biosynthesis of
mtDNA-encoded cIV subunits [e.g. LRPPRC (32), TACO1
(33)]. Pathological COX deficiency has been reported in many
other disorders (34,35), including neurodegenerative conditions
such as Alzheimer dementia (36–38) and Huntington’s disease
(39) although its aetiological significance remains unclear. COX
is also a pathological target in ischaemia, sepsis and other types
of toxic injury (40).
Some cIV subunits are encoded by isogenes differentially
expressed between tissues, where they are adapted to specific
physiological conditions (35,41). Tissues also vary in their sub-
strate dependence, reflected in the degrees to which the different
OXPHOS complexes contribute to threshold effects for respir-
ation (42). Furthermore, supercomplexes, whose formation may
also vary between tissues, entrain a greater or lesser degree of
channelling of respiratory electron flow, and may also limit the
degree to which exogenously introduced alternative respiratory
enzymes can contribute to respiration (18). In a general sense,
these phenomena are believed to contribute to the bewildering
tissue-diversity of mitochondrial disease, though there remain
few concrete mechanistic explanations for this. The relative
importance in COX-associated pathology of disturbed redox
homeostasis, apoptosis induction, deranged cell signalling, ad-
enosine triphosphate (ATP) deficiency, proteotoxic stress and
other types of metabolic disturbance remains a topic of intense
debate.
Thepossibleuseof AOXinfuture therapies for COXdeficiency
will obviously be limited by these considerations, as well as by the
fact that the alternative respiratory chain enzymes do not contrib-
ute directly to ATP production. Completely replacing the function
of one or more OXPHOS complexes cannot completely restore
ATP production capacity to wild-type, even though it can facili-
tate proton-pumping linked to electron transfer at OXPHOS
complexes other than the one(s) it is bypassing. Because AOX
bypasses two of the three proton-translocating steps, it should
not restore ATP production for those substrates whose oxidation
supplies electrons directly to ubiquinone via cII or other
dehydrogenases. Even if AOX can restore redox balance, miti-
gate mitochondrial reactive oxygen species (ROS) production
(6–9) and limit systemic lactic acidosis (6), tissues that
depend on such substrates may still suffer a substantial loss of
function that AOX cannot correct. On the other hand, where
COX activity is limiting for respiration, AOX may promote a sig-
nificant restoration of ATP production (via proton pumping at
other sites), as well as other metabolic benefits.
Drosophila offers a convenient model for human diseases, in-
cluding those affecting mitochondrial functions. The compos-
ition of the OXPHOS complexes, the overall structure and
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gene content of mtDNA and the energetic physiology of the main
organ systems are all similar to those of humans. The fact that
AOX expression in the fly is able to confer cyanide resistance
and overcome the lethality of partial knockdown of Cox6c or
Surf1 raises the question of how far it is able to replace cIV
throughout the life cycle. We thus set out to use the fly as
a model system to address this issue, focusing on three specific
questions relevant to understanding the pathophysiology of
mitochondrial disease and the possible future use of AOX in
therapy. First, what phenotypes result from deficiencies in differ-
ent classes of cIV subunits, and can AOX alleviate these pheno-
types? Secondly, in which tissues is loss of COX function crucial
for producing such phenotypes, and their rescue by AOX?
Thirdly, what residual phenotypes result from replacing cIV func-
tion with AOX? The many genetic tools available in Drosophila
(including effective and specific RNAi in vivo) make it an ideal
tool for such a study, in advance of translating the most prominent
findings to the mouse, which is less flexible, and also takes much
longer and is substantially more expensive to manipulate.
In a first step, to validate use of the inducible (upstream acti-
vating sequence) UAS-AOX transgenic lines that we created
previously, we first conducted an important control to verify
that the rescue seen previously was not subject to any confound-
ing, ‘promoter-dilution’ effects from the simultaneous use of
transgenes dependent on the same transcription factor. We
then proceeded to test the phenotypes generated by knockdown
of different cIV subunits in the whole fly and in specific tissues,
and the ability of AOX to rescue these phenotypes, focusing on
the major differentiated cell-types affected by human mitochon-
drial disease (muscle and neurons).
The results highlight the different phenotypes produced by de-
ficiencies of different subunits, indicate a crucial developmental
role for cIV in muscle and confirm COX deficiency as a cause
of adult-onset neurodegeneration. AOX expression was able to
partially rescue these phenotypes. In contrast, loss of proton-
pumping at cI promotes a distinct phenotype of developmental
delay, bang sensitivity and male infertility.
RESULTS
Constitutive low-level AOX expression confers resistance
to COX inhibition
In previous experiments we expressed inducible AOX using
the UAS/Gal4 (yeast transcription activator protein GAL4)
system, which partially rescued the lethality of cyanide treat-
ment or the disruption of COX by knockdown of the Cox6c
subunit (the cyclope gene: see Table 1) or the Surf1 assembly
factor. However, the UAS/Gal4 system results in a very high
level of transgene expression. Furthermore, since COX knock-
down by RNAi also involves the same induction system, we
cannot completely exclude a contribution to the rescue from pro-
moter competition, even though UAS-GFP (green fluorescent
protein) was unable to rescue. We therefore created transgenic
flies bearing the same AOX transgene, but under the control of
the constitutive a-tubulin promoter (tub-AOX), with independ-
ent single insertions into non-coding DNA on chromosomes X, 2
and 3 (Supplementary Material, Fig. S1A–D). Expression of
these transgenes at the RNA level was 20–50-fold lower than
from UAS-AOX driven by da-GAL4 (Fig. 1A), though still
much higher than UAS-AOX in the absence of a GAL4 driver.
tub-AOX expression was substantially higher in larvae and
adult males than females (Fig. 1A), and was maintained over
the first 2weeks of adult life to a variable extent.
AOX expression at the protein level was also less than when
driven by GAL4, even when we combined tub-AOX insertions
Table 1. Nomenclature, expression patterns and assembly of COX subunits in Drosophila
Subunit
namea
Official gene name(s)
and symbol(s)b
Expression pattern(s)c Commentsd
Cox1 mt CoI Ubiquitous mtDNA-encoded, part of core sub-complex S2
Cox2 mt CoII Ubiquitous mtDNA-encoded, incorporated into sub-complex S3
Cox3 mt CoIII Ubiquitous mtDNA-encoded, incorporated into sub-complex S3
Cox4 CoIV Ubiquitous Two isogenes with different expression patterns, part of core sub-complex S2
CG10396 Testis-specific
Cox5a CoVa Ubiquitous Part of core sub-complex S2
Cox5b CoVb Ubiquitous Incorporated into sub-complex S3
Cox6a levy Ubiquitous Incorporated at final assembly steps into mature complex IV; levy1 splice-site
mutant manifests adult-onset neurodegeneration (19)
Cox6b CoVIb Ubiquitous Incorporated into sub-complex S3
Cox6c cyclope Ubiquitous Null-mutant larval lethal, incorporated into sub-complex S3
Cox7a CG9603 Ubiquitous, lowest in testis Incorporated at final assembly steps into mature complex IV; 99% of brain
Cox7a expression contributed by CG9603
CG34172 Mainly muscle-specific (heart crop,
hindgut, carcass, lower in head)
CG18193 Testis-specific
Cox7b None identified Proposed to be required for an early assembly step (28); clear orthologues
identified only in vertebrates
Cox7c CoVIIc Ubiquitous, but low in testis Only recently identified in Drosophila
Cox8 CoVIII Ubiquitous, but low in testis Incorporated into sub-complex S3
aUsing mouse nomenclature. Note that, some subunits are encoded by gene families in mouse but single genes in Drosophila, and vice versa.
bFrom www.flybase.org.
cFrom www.flyatlas.org.
dAssembly program based on Ref. (12).
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on all three major chromosomes into a single line of flies
(Fig. 1B). tub-AOX conferred cyanide resistance to substrate
oxidation by isolated mitochondria (Supplementary Material,
Fig. S1E), and single tub-AOX insertions were able to confer
almost as great a time of resistance to cyanide as UAS-AOX
driven by da-GAL4 (Fig. 1C, compare with Fig. 5A of Ref. 8).
A single copy of tub-AOX was also able to rescue the semi-
lethality of knockdown of either Cox6c (Fig. 2A) or Surf1
(Fig. 2B and C), when RNAi was induced with different doses
of RU486, in the presence of ubiquitously expressed GeneS-
witch, a modified version of GAL4 that is dependent on the
drug for activity. [Note that, for clarity, we use the mammalian
(mouse) names for all subunits and the genes that encode them
throughout the text, indicating the Drosophila gene name only
upon first mention, in Table 1 and in figure legends.] Knockdown
of Cox6c by about 80% at the RNA level, using 10 mM RU486
(Supplementary Material, Fig. S2A), not only resulted in
lethality of about three-quarters of the progeny (Fig. 2A), but
those flies that were able to eclose did so with a 3-day delay
(Fig. 2D), a phenotypic feature seen in many Drosophila
OXPHOS mutants. The presence of tub-AOX corrected both of
these phenotypes (Fig. 2A and D). tub-AOX also enabled devel-
oping flies to reach pupal stage at doses of RU486 that induced
a degree of Surf1 knockdown that prevented any pupariation
of control flies (Fig. 2B). At 0.1 mM of the drug, a substantial
number of tub-AOX expressors even reached eclosion, whereas
only a few viable adults were produced at this dose by control
flies under Surf1 knockdown alone (Fig. 2C).
Extent of COX deficiency rescued by AOX expression
Knockdown of subunits Cox5a or Cox5b also produced an
RU486 dose-dependent lethality (Fig. 2E and F). This enabled
us to test how rescue is affected by the number of constitutively
Figure 1. Transgenic expression of tub-AOX. (A) Quantitative real time-polymerase chain reaction (qRT-PCR) analysis of AOX mRNA expression (normalized
againstRpL32) in transgenic adults and larvae, as indicated. Means+SD of at least three technical replicates of each of at least three biological replicates. Comparing
(upstream activating sequence) UAS-AOX expression driven by da-GAL4 (yeast transcription activator protein GAL4) with that of tub-AOX, P, 0.01 for each sex/
age analysed; similarly, comparingUAS-AOX expression in the absence of driver with that of tub-AOX,P, 0.01 in each case, except where indicated (#), whereP ,
0.05 (Student’s t test, two-tailed, unequal variances). (B) Western blot of AOX protein and adenosine triphosphate (ATP) synthase subunit a (loading control) in
1-day-old adults of the transgenic strains indicated. tub-AOX denotes flies homozygous for each of tub-AOX7, tub-AOX35 and tub-AOX50 transgenes (males are hemi-
zygous for tub-AOX35). Replicate batches of protein extracts from 30 females or 40 males of each genotype are shown in adjacent lanes. (C) Survival time on
cyanide-impregnated agar of flies of the (homozygous) strains indicated. Means+SD of 80–100 flies of each group, in batches of 10 flies per vial. P , 0.01 in
each case, in comparison with w1118 control flies of same sex (Student’s t test, two-tailed, unequal variances). See also Supplementary Material, Figure S1.
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expressed copies of AOX, and to estimate the amount of knock-
down of COX required to produce AOX-rescuable lethality.
A single copy of tub-AOX was sufficient to overcome the lethal-
ity of knocking down Cox5a or Cox5b to about half of the
wild-type level at larval stage L3 (Supplementary Material,
Fig. S2A), which also produced a decrease of about 50% in the
enzymatically measured COX activity (Supplementary Material,
Fig. S2B). Flies rescued from the lethality of Cox5a or Cox5b
knockdown by two copies of tub-AOX eclosed with a slight, but
statistically non-significant developmental delay (Supplementary
Material, Fig. S2D). The rescued flies were fertile when mated to
wild-type flies of the opposite sex.
Flies in which Cox5b was knocked down during development
by a higher dose (3 mM) of RU486, failed to develop beyond the
larval stage, but four copies of tub-AOX enabled the flies to reach
pupal stage, with 12% of the pupae eclosing. The flies were tested
for bang sensitivity, a sensorineural phenotype associated with
mitochondrial dysfunction, but no bang sensitivity was found
(Supplementary Material, Fig. S2E).
Having excluded promoter-dilution effects as a reason for AOX
rescue of COX deficiency, we set out to use the UAS-AOX lines, in
combination with different GAL4 drivers, to analyse the develop-
mental phenotypes produced by knockdown of COX subunits, and
the degree to which AOX expression is able to complement them.
AOX expression rescues developmental lethality of COX
knockdown
The nuclear-coded subunits of cIV are believed to confer various
regulatory properties on COX, as well as being required for its
proper assembly and stability. Deficiency of specific subunits
leads to the accumulation of various assembly intermediates
Figure 2.Rescue of COX deficiency by tub-AOX. (A) tub-AOX rescue of developmental lethality and (D) of developmental delay, from partial knockdown of Cox6c
(Drosophila gene cyclope) using tub-GS driver. Proportion of eclosing progeny or eclosion day for different genotypes and concentrations of RU486 as shown,
means+SD from 4 or more biological replicates. (B and C) tub-AOX rescue of developmental lethality from partial knockdown of Surf1 using tub-GS driver.
The number of pupae or eclosing flies for different genotypes and concentrations of RU486 as shown, means+SD from 3 or more biological replicates. (E and
F) Rescue of developmental lethality from partial knockdown of Cox5a or Cox5b (Drosophila genesCoVa,CoVb) using tub-GSdriver, as shown. Number of eclosing
progeny at different concentrations of RU486, for the indicated numbers of tub-AOX transgenes. Means+SD from 3 or more biological replicates.P , 0.01 (∗) or,
0.05 (#), Student’s t test, two-tailed, unequal variances, comparing flies with and without tub-AOX. See also Supplementary Material, Figure S2. Note that at 0 mM
RU486 all knockdown lines tested were indistinguishable from wild-type flies in the assays shown, and that wild-type flies eclose on Days 10 and 11 at 258C. Two
copies of tub-AOX also rescued the lethality of Cox6b knockdown (Supplementary Material, Fig. S2C).
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and to subtly different phenotypes. Most nuclear-coded subunits
of COX in Drosophila are encoded by single-copy nuclear
genes (Table 1). Two notable exceptions are Cox4, encoded by
a specific isogene (CG10396) in testis, with a second isogene
(CoIV, CG10664) expressed ubiquitously, and subunit Cox7a,
also encoded by testis-specific (CG18193) and ubiquitous
(CG9603) isogenes, plus an additional, widely expressed
isogene (CG34172), prominently expressed in muscle (carcass,
crop, hindgut and heart).
Using da-GAL4 to drive simultaneously the high-level ex-
pression of UAS-AOX and the knockdown of nuclear-coded
COX subunits in the whole developing fly, we delineated
the limits of AOX rescue of COX deficiency. Knockdown of
the somatic Cox4 isogene produced early larval lethality
(Fig. 3A), consistent with the involvement of this subunit in an
essential early step in cIV assembly, and its requirement for
the production of an enzymatically functional complex. Knock-
down larvae survived for at least 15 days, but never developed
beyond a morphologically abnormal L1 or L2 stage (Fig. 3A),
whereas co-expression of UAS-AOX enabled development
to proceed as far as the pupal stage (Fig. 3A), albeit with
very few flies eclosing (Supplementary Material, Fig. S3A).
Blue native polyacrylamide gel electrophoresis (BNE) in-gel
histochemistry confirmed the functional knockdown (≥50% de-
crease of COX activity) at larval stage L3 in the ‘rescued’ flies
(Fig. 3E), as did polarography using a cIV-specific substrate
mix (Fig. 3F). Interestingly, oxygen consumption driven by
cI- or G3PDH-linked substrates was increased compared with
Figure 3. Partial rescue of global COX deficiency byUAS-AOX. (A) Micrographs illustrating typical phenotypes produced by knockdown of Cox4 (Drosophila gene
CoIV) driven by da-GAL4. In the absence of transgenic rescue, progeny arrested as abnormal L1/L2 larvae. Co-expression of UAS-AOX enabled development to
proceed as far as late pupa, although few flies eclosed. See also Supplementary Material, Figure S3A. (B) Micrograph illustrating typical pupal-lethal phenotype pro-
duced by knockdown of the major Cox7a-encoding isogene CG9603, driven by da-GAL4. (C) AOX rescue of pupal lethality from Cox7a (CG9603) knockdown.
Proportion of eclosingprogenyfor differentgenotypes as shown,means+SD from 3or more biological replicates.Flieswith theda-GAL4driver have normal bristles,
distinguishing them from those with the Sb balancer. Expression of UAS-AOX produced a full rescue whereas UAS-Ndi1 expression produced none. (D) Ascorbate/
TMPD-driven oxygen consumption of homogenates fromUAS-AOXexpressing L3 larvae or adult flies, with or without knockdown of Cox7a (CG9603). Means+SD
from 3 or more biological replicates; asterisks indicate significant differences (P , 0.01, Student’s t test, two-tailed, unequal variances). (E) BNE gels of mitochon-
drial extracts (37.5 mg mitochondrial protein per lane) from L3 larvae of the genotypes shown, stained histochemically for cI or cIV activity (cIV activity staining
performed for the indicated times). See Ref. 10, Figure 3, for migration of major bands in relation to molecular weight markers on these gels. Asterisk indicates as-
sembly sub-complex S3 (12). (F) Oxygen consumption of homogenates from L3 larvae of the indicated genotypes, driven by different substrate mixes (pyruvate +
proline, G3P and ascorbate + TMPD, respectively, as described in the Materials and methods section for cI-, G3PDH- and cIV-linked respiration. For clarity, oxygen
consumption is expressed as a percentage of corresponding values for control larvae expressing AOX but without RNAi. Means+SD,≥3 biological replicates; aster-
isks indicate significant differences (P, 0.01, Student’s t test, two-tailed, unequal variances).
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control larvae, suggesting a compensation for missing proton-
pumping activity in response to AOX ‘replacement’ of the
depleted cIV.
Expression of UAS-Ndi1 as a control produced no rescue of
Cox4 knockdown (Supplementary Material, Fig. S3A). Knock-
down of Cox5b produced a similar larval-lethal phenotype that
was also partially rescued by UAS-AOX, allowing flies to
develop to pupal stage, with 5–10% of pupae eclosing as
viable flies (Supplementary Material, Fig. S3B).
Subunit Cox7a is required for the assembly of the fully func-
tional holoenzyme, but not for the formation of an enzymatically
active sub-complex (denoted as assembly intermediate S3).
Knockdown of the major isogene for Cox7a (CG9603) also
resulted in lethality, but in contrast to the early larval lethality
produced by knockdown of core subunits, Cox7a knockdown
produced lethality only at the pupal stage (Fig. 3B). This was
completely rescued by co-expression of UAS-AOX (Fig. 3C),
but not by UAS-Ndi1 (Fig. 3C). Consistent with the incorpor-
ation of Cox7a at a late stage in cIV assembly and the partial re-
dundancy of the major Cox7a-encoding isogene CG9603 with
isogene CG34172 in some tissues, knockdown of CG9603
resulted in only a partial loss of respiratory capacity in the
whole fly, based on polarography (Fig. 3D) or BNE in-gel histo-
chemistry (Fig. 3E), with a clear accumulation of assembly sub-
complex S3 in L3 larvae.
AOX-rescuable pupal lethality due to COX knockdown is
primarily a muscle phenotype
To test the tissue(s) in which COX expression is critical for the
completion of development, we employed a set of tissue-specific
drivers to knockdown either of the enzymatically crucial subunits
Cox5b (Fig. 4A) or Cox6b (Supplementary Material, Fig. S4A).
No lethality was produced by Cox5b knockdown using any of
five nervous system-specific drivers, two of which are active in
all neurons (elav-GAL4 located on chromosome 3, Bloomington
strain 8760 and nrv2-GAL4), nor were the progeny flies bang-
sensitive (Supplementary Material, Fig. S4B). Lethality was
also not produced with driver BG57 (Fig. 4A), which expresses
in larval muscles from L2 stage and in pupal and adult stages
Figure 4. AOX rescue of tissue-restricted cIV knockdown. (A–C) Knockdown of Cox5b (Drosophila gene CoVb) using the drivers indicated. Flies with the CyO
balancer marker are progeny from the same crosses, but without driver. (A and B) Proportion of eclosing progeny of the genotypes indicated, means+SD for 3
or more biological replicates. (C) Climbing index (defined as in the Materials and methods section) of 1-day-old UAS-AOX transgenic flies bearing the G14
driver, with and without knockdown of Cox5b. Means+SD of 10 batches of 5 flies, for each sex and genotype. Note that the AOX-rescued Cox5b-knockdown
males were unable to climb at all in this experiment. (D and E) Survival curves of flies of the indicated genotypes, following Cox5b or Cox4 (Drosophila gene
CoIV) knockdown and transgene expression driven by (D) elav-GAL4 strain 458 or (E) 8760, as shown. Data are means from two independent experiments. See
also Supplementary Material, Figure S4.
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predominantly in abdominal muscle (Supplementary Material,
Fig. S5A). However, knockdown using driver G14, which ex-
presses mainly in the thoracic muscles (Supplementary Material,
Fig. S5B), produced lethality (Fig. 4A and B), with flies dying at
the late pupal stage or during attempted eclosion. Cox6b knock-
down gave similar results (Supplementary Material, Fig. S4A).
Co-expression of AOX in the same tissues via UAS-AOX re-
scued the lethality of Cox5b knockdown by the G14 driver
(Fig. 4B). Multiple copies of tub-AOX also rescued this lethality,
though less completely (Supplementary Material, Fig. S4C).
Flies rescued by UAS-AOX from the muscle-specific lethality
of Cox5b knockdown nevertheless manifested a severe loco-
motor defect (Fig. 4C), and all died within 2 weeks, as a result
of becoming trapped in the food.
AOX rescue of phenotypes produced by COX knockdown
using neuron-specific drivers
The failure to induce lethality by COX knockdown in neurons is
superficially surprising. We first verified this for knockdown
of a further COX subunit (Cox4), which gave a similar result
(Supplementary Material, Fig. S4D). Next, we tested a second
elav-GAL4 driver located on chromosome X (Bloomington
strain 458). Different crosses were implemented, so as to study
females heterozygous for the driver, plus males hemizygous
for the driver, or control males lacking the driver completely
(Supplementary Material, Fig. S4E, Supplementary Material,
Table S1), as well as any rescue produced by UAS-AOX (or
UAS-Ndi1). In general, elav-GAL4 driver strain 458 produced
stronger effects than driver strain 8760, and stronger phenotypes
for knockdown of Cox4, which was now almost completely
lethal (Supplementary Material, Fig. S4E and F), than for Cox5b.
Males were also more affected than heterozygous females. Ex-
pression of AOX, but not Ndi1, improved all phenotypes. Viable
Cox5b-knockdown flies were transferred to fresh vials and their
survival tracked over 2 weeks (Fig. 4D). All genotypes manifested
locomotor impairmentafter severaldays,whichwasmoresevere in
males. Females with or without co-expression of AOX survived
throughout the experiment, but half of the females co-expressing
Ndi1 died by 2 weeks. Cox5b-knockdown males had a mean life-
span of just 8 days, but co-expression of AOX enabled most flies
to survive at least 2 weeks. In contrast, Cox5b-knockdown males
co-expressing Ndi1 all died after only a few days.
When knockdown was driven by nrv2-GAL4 or the autoso-
mally located elav-GAL4 driver (Bloomington strain 8760)
the outcome of similar survival experiments was much milder.
Cox4 knockdown again gave a stronger phenotype than that of
Cox5b, and was again stronger in males than females. After 2
weeks, some of the flies with Cox4 knocked down by the
nrv2-GAL4 driver had died (though this varied between experi-
ments), whereasCox5bknockdown using thenrv2-driver did not
impair survival over 2 weeks at all.Cox4knockdown by the auto-
somal elav-GAL4 driver (Fig. 4E) produced a similar effect
as Cox5b knockdown by the stronger, X-chromosomal elav-
GAL4 driver (Fig. 4D). Knockdown flies were able to climb,
and were observed feeding, although mostly remained motion-
less, whereas flies co-expressing AOX were normally active
and able to fly. Most knockdown males died within a few days,
a phenotype exacerbated by co-expression of Ndi1, whereas
80% of males co-expressing AOX survived at least 2 weeks.
Females were less affected, though followed a similar pattern
as with Cox5b knockdown driven by X-chromosomal elav-
GAL4, with AOX affording protection against early death.
To account for the inconsistency between the effects of knock-
down using different neuron-specific drivers we re-examined the
tissue-specificity of these drivers, using UAS-GFP (Stinger or
mCD8) as a reporter (Supplementary Material, Fig. S5) and by
immunocytochemistry and histochemistry (Supplementary Ma-
terial, Fig. S6). These experiments revealed that expression
driven by nrv2-GAL4 driver was indeed much weaker than that
driven by elav-GAL4, while the latter gave also a very weak ex-
pression in thoracic muscles at pupal stage (see legends to Sup-
plementary Material, Figs S5 and S6 for detailed explanations).
Serial sections of the brain and thoracic muscle revealed no gross
anatomical defects from Cox4 knockdown using even the stron-
gest elav-GAL4 driver (Supplementary Material, Fig. S6G).
AOX partially rescues adult neurodegeneration caused
by COX deficiency
In order to confirm that the degenerative phenotypes produced
by elav-GAL4 driven COX knockdown and partially rescued
by AOX expression were indeed neuronal, we adopted two strat-
egies. First, we took advantage of the fact that Cox7a in muscle is
predominantly encoded by isogene CG34172, allowing us to
knock down the ubiquitously expressed isogene CG9603 specif-
ically in neurons using elav-GAL4, with minimal effects on
muscle. Secondly, we analysed the effects of AOX expression
in the levy1 mutant in the gene encoding Cox6a, a subunit re-
quired for dimerization of cIV. The splice-site mutation results
in a frameshift early in the polypeptide sequence, and produces
an adult-onset neurodegenerative phenotype (19).
Neuronal depletion of Cox7a driven by elav-GAL4 resulted
in locomotor dysfunction (Fig. 5A) and seizure sensitivity at
298C (Fig. 5B), both of which were partially rescued by co-
expression of AOX. Neither phenotype was produced by
muscle-specific knockdown using the G14 driver (Fig. 5A and
B), as expected, given that Cox7a expression in muscle relies
mainly on isogene CG34172. Cox7a function is also required
during development (Fig. 3C), but AOX-rescue of the lethality
gave an adult phenotype similar to that seen in flies specifically
knocked down for Cox7a and rescued by AOX co-expression in
neurons, namely a mild but progressive locomotor defect
(Fig. 5C) and seizure sensitivity at 298C, which was also progres-
sive (Fig. 5D). However, the rescued flies showed normal sur-
vival at 2 weeks. When mated to wild-type flies of the opposite
sex, males and females were both fertile and their progeny
appeared normal. This contrasts with the phenotype exhibited
by flies knocked down for subunits of cI, but rescued by Ndi1
(Supplementary Material, Fig. S7), which includes pronounced
developmental delay, bang sensitivity at room temperature im-
mediately upon eclosion, and male sterility.
Ubiquitous AOX expression using either tub-AOX (Fig. 6A)
or UAS-AOX driven by da-GAL4 (Fig. 6B) also alleviated
the temperature-dependent seizure sensitivity exhibited by
levy1 mutant flies, although effects on lifespan at 298C were
minimal (Supplementary Material, Fig. S8A–C). Expression
of UAS-Ndi1 in place of UAS-AOX did not alleviate the seizure
sensitivity of levy1 flies (Supplementary Material, Fig. S8D),
instead mildly exacerbated it, similar to the observation that
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Ndi1 expression enhanced the degenerative effects of Cox5b
knockdown by elav-GAL4 (Fig. 6D and E).
Although levy1was previously suggested to be a null mutation
(of Cox6a), we also tested the effects of Cox6a knockdown
by RNAi. Ubiquitous knockdown was semi-lethal to females
at pupal stage (Fig. 6C), although the degree of male lethality
varied between experiments. Eclosing flies failed to inflate
their wings and died in the food shortly after eclosion. Co-
expression of UAS-AOX partially rescued female lethality
(Fig. 6C, Supplementary Material, Fig. S8E), but the resulting
flies were still weak. Knockdown of Cox6a using the muscle-
specific driver G14 did not produce the uninflated wings pheno-
type (0 of 143 flies analysed), whereas elav-GAL4 did so (223 of
237 flies). Co-expression of AOX rescued this phenotype, with
only 9 of 129 flies failing to inflate wings at eclosion (Supple-
mentary Material, Fig. S8E). The Cox6a knockdown phenotype
thus appears to be neuronal and again partially rescued by AOX.
The more severe organismal phenotype produced by Cox6a
knockdown than by the levy1 splice-site mutation in Cox6a
was reflected in a more severe biochemical phenotype as
detected by BNE in-gel histochemistry (Fig. 6D). BNE gels
revealed a multiplicity of complexes showing COX activity, cor-
responding to monomeric and dimeric cIV, as well as supercom-
plexes that were not fully characterized. Knockdown of Cox6a
resulted in a clear and reproducible increase in the mobility of
the monomeric complex, and a substantial decrease in the abun-
dance of all multimeric and supercomplexes. One of these
comigrated on gels with the major complex exhibiting cI activ-
ity, and cI activity based on this assay was also clearly decreased
in Cox6a knockdown flies, though was hardly affected by the
levy1 mutation.
Table 2 shows a summary of the different phenotypes pro-
duced by knockdown of COX subunits using various drivers,
and their alleviation by tub-AOX and/or UAS-AOX in the
experiments described above.
DISCUSSION
AOX can partially replace the functions of COX in vivo
Despite a much lower level of expression than with the GAL4
system, AOX expressed constitutively under the a-tubulin pro-
moter was effective in combating diverse insults affecting cIV
integrity or activity. Flies were protected from cyanide toxicity
and from genetic manipulations of Cox6c (cyclope) or the cIV
assembly factor Surf1, to approximately the same extent as
when AOX expression was driven by ubiquitously expressed
GAL4 (8). These findings indicate, furthermore, that AOX
rescue driven by GAL4 or GeneSwitch is not due to promoter di-
lution effects, and thus validate the use of GAL4 drivers in the
remainder of the experiments reported here.
The phenotypes associated with knockdown of most nuclear-
coded subunits of cIV were significantly alleviated by tub-AOX
expression, including Cox4, Cox5a, Cox5b, Cox6a, Cox 6b and
Figure5.AOX partially rescuesneuronal phenotypes resulting from Cox7a knockdown. (AandC) Climbing index and (BandD) bang sensitivityat 298C of flies of the
indicated genotypes, ages and sex. Means+SD generated by analysis of batches of.50 individual flies of each class. Where, indicated,P , 0.001, Student’s t test,
two-tailed, unequal variances, (A and B) comparing flies knocked down for Cox7a (isogeneCG9603) with and without co-expression of AOX or (C and D) comparing
flies of a given sex expressing AOX, with or without concomitant knockdown of Cox7a.
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Cox6c. tub-AOX also partially complemented a null mutant in
the single-copy gene for Cox6a (levy1). Although tub-AOX ex-
pression of was 3- to 5-fold less in adult females than males
(Fig. 1A and B), the phenotypic rescue of COX inhibition that
it produced was not substantially different between the sexes,
suggesting that only a modest expression of AOX suffices to
ameliorate the major consequences of severe COX deficiency.
The complete absence of COX activity, e.g. via a null muta-
tion for Cox6c (cyclope), produces early developmental lethality
which AOX is unable to compensate (8). However, AOX was
able to complement the lethality of a partial loss of COX activity,
such as produced by a limited RNAi targeted on essential subu-
nits (Figs 2–4). This allows the level of COX activity which is
needed in order to sustain development to be crudely estimated.
Thus, the 50% drop in the level of COX activity in L3 larvae,
brought about by da-GAL4-driven Cox4 knockdown (Fig. 3E
and F), or Cox5b knockdown by the GeneSwitch driver in pres-
ence of 0.5 mM RU486 (Supplementary Material, Fig. S2B), is
larval lethal in the absence of AOX, and very close to the
amount of knockdown that blocks the completion of metamor-
phosis even in the presence of AOX (Supplementary Material,
Fig. S3A). Note that many more flies completed development
when Cox5b knockdown was brought about by GeneSwitch,
with AOX supplied from just two copies of tub-AOX (Fig. 2F),
than when knockdown and rescue were both driven by da-
GAL4 (Supplementary Material, Fig. S3B). This may be ex-
plained by the fact that the GeneSwitch driver is dependent on
the supply of the inducing drug, so that during metamorphosis,
when the flies are not eating, but the drug previously ingested
can be metabolized, GeneSwitch driven-RNAi decays.
da-GAL4-driven RNAi targeted against genes for catalytical-
ly essential subunits, such as Cox4, Cox5a or Cox5b, was lethal
at an early (L1/L2) larval stage, although the abnormal larvae
survived a further 2 weeks without further growth. Similar phe-
notypes have been seen for other manipulations affecting mito-
chondrial OXPHOS, such as knockdown of mitochondrial
transcription factor mtTFB2 (43) or the cIV assembly factor
CCDC56 (44). The implication is that larvae can survive for
long periods on the small amount of OXPHOS capacity acquired
maternally, but require additional respiratory or ATP-generating
potential for growth and developmental progression. AOX ex-
pression allowed this developmental block to be overcome,
Figure 6.AOX partially rescues Cox6a-dependent neurodegeneration. (A andB) Rescue of seizure sensitivity of 7-day-old levy1 flies maintained at 298C. Means+
SD of square root of recovery timefrom mechanical shock, forbatches of50–100 individualflies of the sex and genotypes indicated. Note that, control flies do not show
any such bang sensitivity (zero recovery time). (C) UAS-AOX rescue of semi-lethality of Cox6a knockdown (Drosophila gene levy) in female flies. Means+SD
from 3 or more biological replicates. (D) BNE gels (as Fig. 3E) from 1-day-old adults of the genotype and sex shown, stained histochemically for cI or cIV activity (cIV
activity staining performed for the indicated times). See also Supplementary Material, Figure S7. Where, indicated, P, 0.001, Student’s t test, two-tailed, unequal
variances, comparing flies of the given sex, expressing AOX or not. P ¼ 0.051 in (C).
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although ‘rescued’ flies still died during metamorphosis if COX
activity was below a critical level, and the few flies that eclosed
were typically weak and short-lived. The ability of AOX to
rescue early larval but not pupal lethality does not mean that
the requirement for OXPHOS is greater during metamorphosis
than during larval growth: the maternal contribution to total
COX activity, which may be assumed to be significant in
larvae, becomes enormously diluted during development, on a
per cell basis.
COX deficiency produces a range of adult phenotypes
in Drosophila
Surprisingly, the knockdown of catalytically essential subunits
by pan-neuronal drivers, as well as drivers active in various
Table 2. Phenotypes produced by knockdown or mutation of COX subunits, and rescue by AOX
Genetic lesionb Phenotype Phenotypic rescue by AOX Figure
Cox4 Ubiquitous CoIV knockdown Early larval lethal Pupal lethal with tiny number
of eclosed adults
3A, Supplementary Material,
Figure S3A
CoIV knockdown in neurons Pupal semi-lethal (most flies
too weak to eclose),
surviving adults have short
lifespan (,1 week), varies
with severity of knockdown
Viable, with locomotor defect
but increased lifespan (.2
weeks), varies with severity
of knockdown, but always
improved
4E, Supplementary Material,
Figure S4D–F
Cox5a Ubiquitous CoVa knockdown
(partial)
Lethalc Viable, but with 1–2 days
developmental delay
2E, Supplementary Material,
Figure S2D
Cox5b Ubiquitous CoVb knockdown
(partial)
Lethal Viable, but with 1–2 days
developmental delay, adult
locomotor defect
2F, Supplementary Material,
Figure S2D and F
Ubiquitous CoVb knockdown
(severe)
Early larval lethal Semi-lethal: some viable
adults
Supplementary Material,
Figure S3B
CoVb knockdown in neurons Pupal semi-lethal, adult
females have short lifespan
(1 week), varies with
severity of knockdown
Viable, with locomotor defect
but increased lifespan (.2
weeks), varies with severity
of knockdown but always
improved
4A and D, Supplementary
Material, Figure S4B and E
CoVbknockdown in larval and
adult abdominal muscle
Viablec ntd 4A
CoVb knockdown in thoracic
muscle muscle
Pupal-lethal Viable, but with locomotor
defect
4A–C
Cox6a levy1 mutant Adult-onset, progressive
neurodegeneration and
curtailed lifespan
Greatly alleviated
neurodegeneration; no
effect on lifespan
6A and B, Supplementary
Material, Figure S8A–D
Ubiquitous levy knockdown Lethal in pupa, or immediately
after eclosion (uninflated
wings)
Less pupal lethality (in
females). viable after
eclosion (normal wings)
6C, main text
levy knockdown in neurons Lethal immediately after
eclosion (uninflated wings)
Viable after eclosion (normal
wings)
Supplementary Material,
Figure S2E
levy knockdown in thoracic
muscle
Viable Viable Main text
Cox6b UbiquitousCoVIb knockdown
(partial)
Lethal Viable Supplementary Material,
Figure S2C
CoVIb knockdown in larval
and adult abdominal
muscle
Viable nt Supplementary Material,
Figure S4A
CoVIb knockdown in thoracic
muscle muscle
Pupal (semi-)lethal Viable Supplementary Material,
Figure S4A
CoVIb knockdown in neurons viable nt Supplementary Material,
Figure S4A
Cox6c Ubiquitous cyclope
knockdown (partial)
Semi-lethal, survivors eclose
with 2–3 days delay
Viable, ,1 day
developmental delay
2A and D
Cox7a ubiquitous CG9603
knockdown
Pupal lethal Viable, with mild progressive
neurodegeneration
3B and C, Supplementary
Material, Figure S5C and D
CG9603 knockdown in
neurons
Neurodegeneration Milder neurodegeneration 5A and B
CG9603 knockdown in
thoracic muscle
Wild-type Wild-type 5A and B
Surf1 (assembly
factor)
Surf1 knockdown (partial) (Pupal) semi-lethal Viable 2B and C
aUsing mouse nomenclature, as in Table 1.
bOfficial gene symbols/names as in www.flybase.org.
cPhenotypes listed only as lethal or viable were not investigated further.
dNot tested.
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different subsets of neurons, was non-lethal even in the absence
of AOX (Fig. 4). Previous data are consistent with the idea that
neurons can develop and survive long periods with profound
OXPHOS deficiency. Mice with only 30% of the wild-type
COX activity in the brain, due to a deletion of the Surf1 gene,
are nevertheless viable (45), and postnatal deletion of the Tfam
gene in mouse forebrain neurons produces only a late-onset neu-
rodegeneration, which manifests pathologically a full month
after profound neuronal COX deficiency is seen histochemically
(46). Chimeric mice created using this model also show long-
term survival, even if.50% of neurons are respiration-deficient
(47). In Drosophila, even severe neurodegenerative phenotypes
associated with mitochondrial dysfunction, are non-lethal during
development (48,49).
In contrast, muscle-specific knockdown of COX during devel-
opment, using GAL4 driver G14, was pupal-lethal in the absence
of AOX. This lethality was not produced by driver BG57, which
is active in larval and adult abdominal muscles, but not the thor-
acic muscles that are targeted by G14 (Supplementary Material,
Fig. S5A and B), indicating the latter as the critical target. The
lethality of Cox5b knockdown driven by G14 was fully
rescued by co-expression of AOX, although when knockdown
was driven by da-GAL4 the result was still almost complete
pupal lethality, suggesting that some COX activity in tissues
other than muscle is needed for the completion of development.
Moreover, while the developmental block caused by muscle-
specific knockdown of Cox5b was rescued by AOX, the
eclosed flies were very weak. AOX can thus complement COX
deficiency sufficiently to enable muscle development but can
only do so incompletely for muscle function, indicating that at
least some residual proton-pumping activity at cIII/cIV is essen-
tial for full activity of the tissue. This may mirror the prominence
of muscle involvement in those human mitochondrial diseases
where the primary defect causes only a decrease in the activity
of cIV (20) or cIII (50).
The different phenotypes produced by cIV knockdown using
pan-neuronal drivers partly reflect their different strengths, as
revealed by GFP expression (Supplementary Material, Fig. S5).
Thus, the degenerative phenotypes produced by Cox4 knockdown
rangefrom semi-lethalitywith the stronger,X-chromosomalelav-
GAL4 driver (strain 458), to no detectable impairment within
the first 2 weeks of adult life, for nrv2-GAL4. Autosomal elav-
GAL4 (strain 8760), which drives GFP expression less strongly
in the adult and pupa (Supplementary Material, Fig. S5F–I),
gave an intermediate phenotype. The stronger elav-GAL4-driven
phenotype in males is an expected consequence of dosage com-
pensation of an X chromosome-derived promoter. In addition,
based on GFP (Supplementary Material, Fig. S5F–I) and AOX
expression (Supplementary Material, Fig. S6B), as well as cIV
knockdown as judged by immunocytochemistry (Supplementary
Material, Fig. S6D) and histochemical staining (Supplementary
Material, Fig. S6E and F), the elav-GAL4 drivers are weakly
active also in developing thoracic muscle from the pupal stage.
This complicates the interpretation of the organismal phenotypes
produced using these drivers. The weakness, inactivity and loco-
motor dysfunction produced by elav-GAL4-driven Cox4, Cox5b
or Cox6a knockdown are similar to the effects produced by
muscle-specific driver G14, though vary in degree. They appear
to constitute a stable, developmentally determined phenotype
distinct from the progressive neurodegeneration exhibited by
the Cox6a mutant levy1, which also resembles the other, more
progressive effects of cIV knockdown produced by the elav-
GAL4 drivers.
However, the effects of knockdown of the major somatic
isoform of Cox7a (Fig. 5) indicate that the elav-GAL4-driven
phenotypes produced by knockdown of core subunits of cIV
are, in fact, predominantly or exclusively neural. Data from flya-
tlas.org indicate that the isogeneCG9603 accounts for.99% of
Cox7a expression in the brain. However, in adult carcass, which
consists mainly of muscle tissue, the expression of Cox7a
isogene CG34172 predominates. Consistent with this, the phe-
notypes produced by global knockdown of isogene CG9603
using da-GAL4 in the presence of UAS-AOX (progressive
bang sensitivity and locomotor impairment, Fig. 5C and D)
were not seen when using the muscle-specific driver G14
(Fig. 5A and B), but were produced by the elav-GAL4 driver
(Fig. 5A and B), confirming that these are the characteristic neur-
onal phenotypes of adult COX deficiency in Drosophila. Im-
portantly, these phenotypes were alleviated by the concomitant
expression of AOX, even at relatively modest levels, e.g. tub-
AOX rescue of the levy1 phenotype (Fig. 6A).
Neuronal COX-deficient phenotypes and bioenergetic
insufficiency
AOX rescue of the neuronal phenotypes produced by knockdown
of different cIV subunits was not complete. For example, even
when AOX was co-expressed, Cox7a knockdown still produced
a mild, residual bang sensitivity and locomotor dysfunction that
were not seen in wild-type flies, and which worsened with age
(Fig. 5C and D). Furthermore, although the temperature-
dependent bang sensitivity of levy1 flies was greatly alleviated
by AOX, it was not completely abolished (Fig. 6A and B), and
the short lifespan of levy1 flies was hardly affected (Supplemen-
tary Material, Fig. S7A–C). Importantly, the degree of rescue of
the levy1 phenotype was the same (Fig. 6A and B), even when
AOX was expressed at a much higher level, driven by da-GAL4
(Fig. 1A).
Because it is non-proton-pumping, AOX cannot rescue ATP
production at cIII/cIV. However, by releasing electron flow
from a block at the level of cIV, AOX expression can restore
ATP production due to proton-pumping at cI. In addition, it can
decrease other consequences of cIV inhibition, such as excess
ROS production (6–9), metabolic acidosis or disturbances to
intermediary metabolism and, for unexplained reasons, decreases
mitochondrial ROS production even under non-inhibited condi-
tions [(51), Fig. 3]. The question thus arises as to which of these
effects underlies the neurodegeneration produced by COX defi-
ciency, even in the presence of AOX. Importantly, in this
regard, co-expression of Ndi1 in place of AOX actually worsened
the levy1 phenotype (though this was only statistically significant
in males), and also worsened the degenerative effects of Cox4 or
Cox5b knockdown produced by the elav-GAL4 drivers. Unlike
AOX, expressed Ndi1 appears to be constitutively active (10),
thus divertinga proportion of the electron flowthat shouldnormal-
ly pass through cI and decreasing the total amount of proton-
pumping for a given respiratory flux. Under conditions where
electron flow through cIV is too low, Ndi1 expression should di-
minish further an already insufficient rate of ATP production.
Conversely, it should have no effect on excess ROS production
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at cIII, since coenzyme Q (CoQ) remains maximally reduced
under these conditions. ROS production at cI might actually be
mildly alleviated. Thus, our results strongly suggest that the
primary mechanism of neurodegeneration caused by COX defi-
ciency is a bioenergetic deficit, and not an effect of excess ROS
or metabolic disturbance.
The failure of AOX to improve the short lifespan of levy1
flies, combined with our analysis of the levy1 and Cox6a-KD
phenotypes by BNE (Fig. 6D), suggests that the levy1 mutation
may also act via another mechanism. The Cox6a gene product
appears to be required not only for the dimerization/multimeri-
zation of cIV but also the participation of cIV in respiratory
supercomplexes, including those that also contain cI (Fig. 6D).
Supercomplex formation has elsewhere been shown to be crucial
for full respiratory function (18,52). Moreover, the absence of
Cox6a results in a functional deficiency of both complexes IV
and I. Since other data strongly indicate that loss of cI activity
(10,53), especially in the nervous system (54), is a primary cause
of ageing, the short lifespan of levy1 flies may be due to cI defi-
ciency and/or loss of cI-containing supercomplexes, rather than
COX deficiency as such.
Loss of proton-pumping at cIV or cI produces distinct
organismal phenotypes
The residual phenotypes seen when cIV is functionally replaced
by AOX or when cI is functionally replaced by Ndi1 are distinct.
AOX-rescued cIV-knockdown flies manifest the developmen-
tally determined muscle weakness and neurodegeneration pheno-
types described above, but are fertile, show no bang sensitivity
at room temperature when tested 1–2 days after eclosion, and
suffer only a short (1–2 days) developmental delay. In contrast,
Ndi1-rescued cI-knockdown flies show a pronounced (3–5 days)
developmental delay, bang sensitivity detectable at room tem-
perature immediately after eclosion, and male sterility associated
with greatly decreased amounts of sperm, which are also immo-
tile. However, the Ndi1 rescued flies are normally active, indicat-
ing unimpaired muscle function, and do not show short lifespan or
other signs of neurodegeneration.
These different phenotypes may be considered as an example
of the different respiratory thresholds of different tissues (42).
COX has previously been suggested to have a low reserve cap-
acity in skeletal muscle, based on biochemical threshold mea-
surements of the different OXPHOS complexes in various rat
tissues (42). The dependence of individual tissues on the dif-
ferent OXPHOS complexes is also greatly influenced by the
metabolic fuels that are supplied physiologically. For example,
inhibition of cI should be much less important in a tissue depend-
ent on oxidation of succinate or a-glycerophosphate than one
where pyruvate is the main substrate. In Drosophila flight
muscle, ATP production depends on a combination of glycoly-
sis and a-glycerophosphate oxidation in mitochondria, which
donates directly electrons to cIII via CoQ, using an flavin
adenine dinucleotide-linked enzyme GPD2 (55). This
a-glycerophosphate cycle also sustains the regeneration of nico-
tinamide adenine dinucleotide + without production of lactate,
and its genetic ablation causes loss of viability (56). This is con-
sistent with the greater dependence of muscle on the activity of
cIV as opposed to cI implied by our results, and may also
account for the absence of muscle weakness and pupal lethality
in levy1 flies, where a major effect of the mutation appears to be
the absence of supercomplexes containing cI.
The phenotype of pronounced developmental delay and bang
sensitivity is characteristic ofDrosophilamutants lacking mito-
chondrial OXPHOS capacity, notably sesB1 (57) and tko25t (58).
cI is the most affected of the OXPHOS complexes in tko25t (58).
Based on the patterns of tissue-specific rescue with the wild-type
tkogene, bang sensitivity was suggested to be a neural phenotype
(59,60). Although tko25t exhibits a male courtship defect (58) it is
not sterile. However, the combined phenotype of bang sensitiv-
ity and male sterility has been previously reported in engineered
Drosophila hypomorphs for porin (61,62), showing a similar
sperm defect as seen in Ndi1-rescued cI-knockdown flies. Male
infertility comprising low sperm number (oligozoospermia),
with loss of sperm motility (asthenozoospermia) is a common
phenotype in humans, and has been reported, in specific popula-
tions, in individuals polymorphic for the CAG repeat at the
POLG1 (mtDNA polymerase) locus (63,64), or deriving from
a specific mitochondrial haplogroup (65). Since Ndi1 should
compensate the redox disturbance and excess ROS production
resulting from cI deficiency, our findings indicate a specific im-
portance of proton-pumping at cI for normal sperm differenti-
ation and motility, and may reflect a unique metabolic signature
of sperm (66).
AOX as therapy for COX deficiency based
on the Drosophilamodel
Previous studies in Drosophila (8,49) indicated that AOX
expression is a potentially useful tool for correcting a wide spec-
trum of genetic defects affecting the mitochondrial cytochrome
chain. The present study extends these findings by showing
that AOX can overcome both lethal and tissue-specific effects
of various types of COX deficiency, notably those affecting
early development, muscle differentiation and function and
the functional maintenance of the nervous system during adult
life (Table 2). AOX was able to rescue phenotypes arising
from genetic lesions affecting COX subunits required for early
[Cox4, Cox5a (67)], intermediate (Cox5b, Cox6b) and late
steps (Cox7a) in cIV assembly, a key subunit (Cox6a) required
for cIV multimerization and supercomplex formation, and the
assembly factor Surf1. COX deficiency in humans also has a di-
versity of genetic causes, including catalytic (29–31) and struc-
tural subunits (27,28), assembly factors (22,23,25,26) and genes
required for biosynthesis (32,33). Pathological COX deficiency
is ALSO among the most severe manifestations of mitochondrial
disease. Developing AOX as a wide-spectrum genetic therapy is
thus an attractive, if distant goal.
MATERIALS ANDMETHODS
Drosophila stocks and maintenance
w1118 flies, standard balancers, UAS-GFP lines (Stinger with an
insertion on chromosome 2 and mCD8 on chromosome 3) and
GAL4 driver lines were obtained from stock centres. G14-GAL4
(68) was a kind gift from Professor John C. Sparrow (University
of York) and the tubulin-GeneSwitch (tub-GS) driver (69) from
Dr Scott Pletcher (University of Michigan). The Surf1-KD line
79.1 (70), levy1 mutant strain (19), UAS-AOX transgenic lines
AOXF6 and AOXF24 (8) and UAS-Ndi1 transgenic line A46 (10)
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were described previously. RNAi stocks targeted against cyclope,
CoIV, CoVa, CoVb, levy, CoVIb, CG9603, CG6020 and CG3683
(71) were from the Vienna Drosophila RNAi Centre (VDRC).
All flies were maintained in standard medium (8), with addition
of RU486 (Mifepristone, Sigma, St Louis, MO, USA) for induction
of expression using the tub-GS driver.
Generation of tub-AOX transgenic lines
Trasgenic lines containing Ciona intestinalis AOX under the
control of the Drosophila aTub84B promoter were created,
using, a modified pGREEN-H-Pelican vector (72) (Drosophila
Genomics Resource Center, Bloomington, IN, USA) as previ-
ously described (8). Insertion sites were determined by inverse
polymerase chain reaction (PCR) (8).
Developmental time, behavioural, toxin resistance
and lifespan assays
Crosses were conducted in triplicate, and mean developmental
time to eclosion at 258C and bang sensitivity measured as de-
scribed previously (73). Resistance to cyanide and climbing
ability were assayed essentially as described in Ref. (8), with
minor modifications (8, see SI). For lifespan curves, virgin
females and males were collected in sets of 10 flies per vial,
and transferred to fresh food vials three times a week, as previ-
ously (10). At least 10 vials of each sex and genotype were
used in life-span experiments, or 3 vials of each sex and genotype
when measuring survival over just 2 weeks.
Protein analysis
Mitochondria from batches of 80–100 adult flies or pupae were
isolated essentially as described (74). For isolation of mito-
chondria from L3 larvae, 0.01 M freshly neutralized cysteine
hydrochloride was added to the isolation buffer. SDS-PAGE
and western blotting using antibodies against AOX and ATP
synthase subunit a were as described previously (8). BNE and
in-gel activity staining of mitochondrial enzymes (54) used
NativePAGE Novex Bis-Tris Gel System (Invitrogen Life Tech-
nologies, Carlsbad, CA, USA) and batches of 100 mg of isolated
mitochondria.
RNA extraction and qRT-PCR
RNA extraction from Drosophila adults and larvae, cDNA
synthesis, quantitative real time-polymerase chain reaction
(qRT-PCR) and data analysis were performed as described for
Surf1mRNA in Ref. (8), using primer sets shown in Supplemen-
tary Material, Figure SI.
Metabolic analyses
Polarography was performed using a high-resolution Oroboros
2K respirometer for whole homogenates, as described previous-
ly (75). COX activity was measured using the CYTOCOX1 kit
(Sigma), according to manufacturer’s recommendations.
Imaging
Imaging of the head and thorax was carried out by haematoxylin
and eosin staining of paraffin sections. For immunocytochem-
istry, heat- and Triton X-100-treated paraffin sections were incu-
bated with primary antibodies against COXIV (Abcam, rabbit),
ATP5A (Abcam, mouse) or AOX (21st Century Biologicals,
rabbit), with appropriate secondary antibodies (Invitrogen). Slides
were imaged by spinning disc confocal microscopy. Staining
for COX and SDH activity was carried out on cryosections, es-
sentially as described previously described (76, see Supplemen-
tary Material, Fig. SI).
GFP expression patterns generated by various GAL4 drivers
were determined by crossing homozygous driver and GFP re-
porter lines, with imaging of larvae and dissected organs by
fluorescence microscopy. No image manipulation was done,
other than standard brightness and contrast optimization.
For further details see SI.
SUPPLEMENTARYMATERIAL
Supplementary Material is available at HMG online.
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